Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CLPT ClearPoint Neuro	$13.59 +1.6%	$11.21	$8.27 ▼ $30.10	$401.26M	1.31	640,125 shs	338,271 shs
KIDS OrthoPediatrics	$18.49 +1.4%	$16.98	$14.42 ▼ $23.70	$468.24M	1.03	130,209 shs	105,282 shs
NNOX Nano-X Imaging	$1.67 -8.2%	$2.01	$1.59 ▼ $5.72	$126.65M	1.21	1.23 million shs	1.02 million shs
NPCE NeuroPace	$15.96 +2.1%	$16.00	$7.56 ▼ $19.60	$532.89M	1.88	163,584 shs	96,174 shs

Reduce the Risk

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CLPT ClearPoint Neuro	+1.57%	+9.86%	+6.01%	+16.95%	+2.10%
KIDS OrthoPediatrics	+1.43%	+9.99%	+3.82%	+3.88%	-14.16%
NNOX Nano-X Imaging	-8.24%	-13.02%	-3.47%	-36.50%	-69.75%
NPCE NeuroPace	+2.11%	-2.03%	-13.02%	+9.24%	+23.43%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CLPT ClearPoint Neuro	$13.59 +1.6%	$11.21	$8.27 ▼ $30.10	$401.26M	1.31	640,125 shs	338,271 shs
KIDS OrthoPediatrics	$18.49 +1.4%	$16.98	$14.42 ▼ $23.70	$468.24M	1.03	130,209 shs	105,282 shs
NNOX Nano-X Imaging	$1.67 -8.2%	$2.01	$1.59 ▼ $5.72	$126.65M	1.21	1.23 million shs	1.02 million shs
NPCE NeuroPace	$15.96 +2.1%	$16.00	$7.56 ▼ $19.60	$532.89M	1.88	163,584 shs	96,174 shs

Reduce the Risk

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CLPT ClearPoint Neuro	+1.57%	+9.86%	+6.01%	+16.95%	+2.10%
KIDS OrthoPediatrics	+1.43%	+9.99%	+3.82%	+3.88%	-14.16%
NNOX Nano-X Imaging	-8.24%	-13.02%	-3.47%	-36.50%	-69.75%
NPCE NeuroPace	+2.11%	-2.03%	-13.02%	+9.24%	+23.43%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CLPT ClearPoint Neuro	2.33	Hold	$18.00	32.45% Upside
KIDS OrthoPediatrics	2.82	Moderate Buy	$24.44	32.20% Upside
NNOX Nano-X Imaging	2.83	Moderate Buy	$5.00	199.40% Upside
NPCE NeuroPace	2.88	Moderate Buy	$18.83	18.00% Upside

Current Analyst Ratings Breakdown

Latest NNOX, NPCE, KIDS, and CLPT Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
6/9/2026	CLPT ClearPoint Neuro	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$16.00
5/15/2026	NPCE NeuroPace	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$19.00 ➝ $20.00
5/8/2026	CLPT ClearPoint Neuro	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$16.00
5/1/2026	KIDS OrthoPediatrics	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$17.00
5/1/2026	KIDS OrthoPediatrics	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$24.00
4/24/2026	KIDS OrthoPediatrics	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$25.00
4/22/2026	NNOX Nano-X Imaging	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold ➝ Strong Sell
4/21/2026	KIDS OrthoPediatrics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
4/20/2026	CLPT ClearPoint Neuro	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
4/20/2026	NNOX Nano-X Imaging	D. Boral Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$5.00
4/13/2026	NNOX Nano-X Imaging	D. Boral Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$5.00

(Data available from 6/10/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CLPT ClearPoint Neuro	$36.97M	11.02	N/A	N/A	$0.99 per share	13.73
KIDS OrthoPediatrics	$236.35M	2.01	$0.17 per share	109.63	$13.82 per share	1.34
NNOX Nano-X Imaging	$13.02M	8.93	N/A	N/A	$2.01 per share	0.83
NPCE NeuroPace	$99.99M	5.44	N/A	N/A	$0.57 per share	28.00

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CLPT ClearPoint Neuro	-$25.54M	-$1.01	N/A	N/A	N/A	-71.57%	-140.96%	-36.98%	8/11/2026 (Estimated)
KIDS OrthoPediatrics	-$39.65M	-$1.68	N/A	N/A	N/A	-16.31%	-7.01%	-4.86%	8/4/2026 (Estimated)
NNOX Nano-X Imaging	-$75.02M	-$1.59	N/A	N/A	N/A	-790.87%	-64.65%	-57.27%	7/20/2026 (Estimated)
NPCE NeuroPace	-$21.47M	-$0.65	N/A	N/A	N/A	-21.67%	-108.20%	-18.50%	8/11/2026 (Estimated)

Latest NNOX, NPCE, KIDS, and CLPT Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/13/2026	Q1 2026	CLPT ClearPoint Neuro	-$0.28	-$0.32	-$0.04	-$0.32	$11.97 million	$12.13 million
5/12/2026	Q1 2026	NPCE NeuroPace	-$0.19	-$0.13	+$0.06	-$0.20	$21.65 million	$22.00 million
4/30/2026	Q1 2026	KIDS OrthoPediatrics	-$0.4552	-$0.42	+$0.0352	-$0.45	$58.29 million	$59.36 million
4/20/2026	Q4 2025	NNOX Nano-X Imaging	-$0.15	-$0.50	-$0.35	-$0.50	$3.99 million	$3.72 million
3/17/2026	Q4 2025	CLPT ClearPoint Neuro	-$0.22	-$0.27	-$0.05	-$0.27	$10.40 million	$10.41 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
CLPT ClearPoint Neuro	N/A	N/A	N/A	N/A	N/A
KIDS OrthoPediatrics	N/A	N/A	N/A	N/A	N/A
NNOX Nano-X Imaging	N/A	N/A	N/A	N/A	N/A
NPCE NeuroPace	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CLPT ClearPoint Neuro	2.63	5.79	4.88
KIDS OrthoPediatrics	0.29	5.21	2.37
NNOX Nano-X Imaging	N/A	3.96	3.77
NPCE NeuroPace	4.08	5.38	4.35

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CLPT ClearPoint Neuro	30.08%
KIDS OrthoPediatrics	69.05%
NNOX Nano-X Imaging	21.49%
NPCE NeuroPace	78.83%

Insider Ownership

Company	Insider Ownership
CLPT ClearPoint Neuro	6.94%
KIDS OrthoPediatrics	31.80%
NNOX Nano-X Imaging	N/A
NPCE NeuroPace	20.50%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CLPT ClearPoint Neuro	110	29.99 million	27.91 million	Optionable
KIDS OrthoPediatrics	200	25.68 million	17.52 million	Optionable
NNOX Nano-X Imaging	190	69.59 million	N/A	Optionable
NPCE NeuroPace	170	34.09 million	27.11 million	Optionable

NNOX, NPCE, KIDS, and CLPT Headlines

Recent News About These Companies

NeuroPace Shareholders Approve Directors and Auditor at Meeting

June 8 at 6:30 PM | tipranks.com

Solana (NASDAQ:HSDT) and NeuroPace (NASDAQ:NPCE) Head to Head Contrast

June 3, 2026 | americanbankingnews.com

How The NeuroPace (NPCE) Investment Story Is Shifting Without A New Analyst Price Target

June 2, 2026 | finance.yahoo.com

NPCE Receives FDA Approval for AI-Powered ECoG Assistant for Epilepsy

June 2, 2026 | zacks.com

NeuroPace (NASDAQ:NPCE) versus Autonomix Medical (NASDAQ:AMIX) Head to Head Analysis

May 30, 2026 | americanbankingnews.com

NeuroPace to Highlight Expanding Role of Responsive Neuromodulation at the 2026 American Society for Stereotactic and Functional Neurosurgery (ASSFN) Meeting

May 29, 2026 | businesswire.com

NeuroPace Announces FDA Approval of ECoG Assistant™, Advancing AI-Driven Epilepsy Care

May 29, 2026 | businesswire.com

Analysts Conflicted on These Healthcare Names: NeoGenomics (NEO) and NeuroPace (NPCE)

May 28, 2026 | theglobeandmail.com

Is NPCE Stock a Buy in 2026 After DIXI Exit and Margin Lift?

May 27, 2026 | zacks.com

NPCE Explains How NeuroPace's RNS System Makes Money

May 27, 2026 | zacks.com

NeuroPace NPCE and the Next Wave of AI-Driven Epilepsy Care

May 27, 2026 | zacks.com

NeuroPace (NPCE) Q1 2026 Earnings Transcript

May 15, 2026 | finance.yahoo.com

NeuroPace, Inc. (NASDAQ:NPCE) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

May 15, 2026 | finance.yahoo.com

Neuropace signals $99M-$101M 2026 revenue outlook while targeting 21%-23% underlying RNS growth

May 14, 2026 | seekingalpha.com

NPCE Stock Gains on Q1 Earnings & Revenue Beat, 2026 Outlook Raised

May 13, 2026 | zacks.com

NeuroPace, Inc. (NPCE) Q1 2026 Earnings Call Transcript

May 12, 2026 | seekingalpha.com

NeuroPace Q1 Earnings Call Highlights

May 12, 2026 | marketbeat.com

NeuroPace, Inc. (NPCE) Reports Q1 Loss, Tops Revenue Estimates

May 12, 2026 | zacks.com

NeuroPace Reports First Quarter 2026 Financial Results and Raises 2026 Revenue Guidance

May 12, 2026 | businesswire.com

NeuroPace Inc (NPCE) Q1 2026 Earnings Report Preview: What To Expect

May 11, 2026 | finance.yahoo.com

NeuroPace (NPCE) Moves 6.3% Higher: Will This Strength Last?

May 7, 2026 | zacks.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

NNOX, NPCE, KIDS, and CLPT Company Descriptions

ClearPoint Neuro NASDAQ:CLPT

$13.59 +0.21 (+1.57%)

Closing price 06/9/2026 04:00 PM Eastern

Extended Trading

$13.36 -0.23 (-1.69%)

As of 07:49 AM Eastern

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

OrthoPediatrics NASDAQ:KIDS

$18.49 +0.26 (+1.43%)

Closing price 06/9/2026 04:00 PM Eastern

Extended Trading

$18.42 -0.07 (-0.40%)

As of 05:15 AM Eastern

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

Nano-X Imaging NASDAQ:NNOX

$1.67 -0.15 (-8.24%)

Closing price 06/9/2026 04:00 PM Eastern

Extended Trading

$1.79 +0.12 (+7.19%)

As of 07:42 AM Eastern

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source, and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide, as well as customers to obtain remote interpretations of imaging data; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans for osteoporosis and cardiovascular disease; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities; and multi-specialty physician groups, contracts, and radiology readings. The company is headquartered in Petach Tikva, Israel.

NeuroPace NASDAQ:NPCE

$15.96 +0.33 (+2.11%)

Closing price 06/9/2026 04:00 PM Eastern

Extended Trading

$15.96 -0.01 (-0.03%)

As of 06/9/2026 07:09 PM Eastern

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy. It also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest NNOX, NPCE, KIDS, and CLPT Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest NNOX, NPCE, KIDS, and CLPT Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

NNOX, NPCE, KIDS, and CLPT Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

NNOX, NPCE, KIDS, and CLPT Company Descriptions

ClearPoint Neuro NASDAQ:CLPT

OrthoPediatrics NASDAQ:KIDS

Nano-X Imaging NASDAQ:NNOX

NeuroPace NASDAQ:NPCE

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest NNOX, NPCE, KIDS, and CLPT Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest NNOX, NPCE, KIDS, and CLPT Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

NNOX, NPCE, KIDS, and CLPT Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

NNOX, NPCE, KIDS, and CLPT Company Descriptions

ClearPoint Neuro NASDAQ:CLPT

OrthoPediatrics NASDAQ:KIDS

Nano-X Imaging NASDAQ:NNOX

NeuroPace NASDAQ:NPCE

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools